The reporting odds ratio versus the proportional reporting ratio: 'deuce'
- PMID: 15317032
- DOI: 10.1002/pds.1002
The reporting odds ratio versus the proportional reporting ratio: 'deuce'
Comment on
-
The reporting odds ratio and its advantages over the proportional reporting ratio.Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):519-23. doi: 10.1002/pds.1001. Pharmacoepidemiol Drug Saf. 2004. PMID: 15317031 Review.
Similar articles
-
The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions.Pharmacoepidemiol Drug Saf. 2005 Apr;14(4):285-6. doi: 10.1002/pds.1058. Pharmacoepidemiol Drug Saf. 2005. PMID: 15782397 No abstract available.
-
The reporting odds ratio and its advantages over the proportional reporting ratio.Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):519-23. doi: 10.1002/pds.1001. Pharmacoepidemiol Drug Saf. 2004. PMID: 15317031 Review.
-
Quantitative signal detection using spontaneous ADR reporting.Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):427-36. doi: 10.1002/pds.1742. Pharmacoepidemiol Drug Saf. 2009. PMID: 19358225 Review.
-
Exposure-time-varying hazard function ratios in case-control studies of drug effects.Pharmacoepidemiol Drug Saf. 2006 Feb;15(2):81-92. doi: 10.1002/pds.1164. Pharmacoepidemiol Drug Saf. 2006. PMID: 16287211
-
Adverse drug events in cognitively impaired elderly patients.Dement Geriatr Cogn Disord. 2007;23(6):395-400. doi: 10.1159/000101454. Epub 2007 Mar 29. Dement Geriatr Cogn Disord. 2007. PMID: 17396031
Cited by
-
The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.Eur J Clin Pharmacol. 2013 May;69 Suppl 1:33-41. doi: 10.1007/s00228-013-1486-8. Epub 2013 May 3. Eur J Clin Pharmacol. 2013. PMID: 23640186
-
Assessment of safety profile of secukinumab in real-world scenario using United States food and drug administration adverse event reporting system database.Sci Rep. 2024 Jan 12;14(1):1222. doi: 10.1038/s41598-023-50013-7. Sci Rep. 2024. PMID: 38216608 Free PMC article.
-
Using multiple drug similarity networks to promote adverse drug event detection.Heliyon. 2024 Nov 5;10(22):e39728. doi: 10.1016/j.heliyon.2024.e39728. eCollection 2024 Nov 30. Heliyon. 2024. PMID: 39748955 Free PMC article.
-
Data mining of the public version of the FDA Adverse Event Reporting System.Int J Med Sci. 2013 Apr 25;10(7):796-803. doi: 10.7150/ijms.6048. Print 2013. Int J Med Sci. 2013. PMID: 23794943 Free PMC article. Review.
-
Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports.Cardiooncology. 2022 Jul 19;8(1):13. doi: 10.1186/s40959-022-00139-w. Cardiooncology. 2022. PMID: 35854393 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical